Department of Immunotechnology
1 – 15 of 84
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Establishment and Characterization of Innovative Immunoreagents for Diagnosis of Neurodegenerative Disease
(
- Master (Two yrs)
-
Mark
Exploring the potential of saruparib in overcoming venetoclax resistance in AML
(
- Master (Two yrs)
- 2023
-
Mark
Investigations of immune population subsets in bladder cancer
(
- Master (Two yrs)
-
Mark
Dendritic cell stress responses after exposure to a novel rubber skin sensitizer
(
- Master (Two yrs)
-
Mark
Development of in vitro models that test and predict immune-mediated adverse toxicities
(
- Master (Two yrs)
-
Mark
Evaluating targeted combination therapies in EGFR wild-type non-small-cell lung cancer using mass spectrometry-based proteomics
(
- Master (Two yrs)
-
Mark
Towards Development of Antibodies Targeting Myeloid and Regulatory T Cells in Bladder Tumours
(
- Master (Two yrs)
-
Mark
Mass spectrometry-based proteomic characterization of peripheral immune cells
(
- Master (Two yrs)
-
Mark
Immune cell landscapes in endometriosis and endometriosis-associated ovarian cancer
(
- Master (Two yrs)
-
Mark
The Frequency and Biological Impact of CD25 Expression in Mantle Cell Lymphoma
(
- Master (Two yrs)
-
Mark
The bispecific CD40xEpCAM antibody increase activation in human antigen presenting cell subsets and induce CD8+ T cell proliferation to a greater extent compared to monospecific antibodies
(
- Univ. Diploma
-
Mark
Development and testing of autologous in vitro models for their ability to mimic the immune system’s response toward immunotherapies
(
- Master (Two yrs)
-
Mark
Characterization of SLC40A1 in Acute Myeloid Leukemia by CRISPRi Gene Editing
(
- Master (Two yrs)
-
Mark
Study of the immunological response from an OMV-based vaccine using ELISA
(
- Master (Two yrs)
-
Mark
Sex differences in Health and Disease
(
- Master (Two yrs)